Eusol Biotech Co.,Ltd. (6652.TWO)
TWD 6.05
(-22.34%)
TWD 6.05
(-22.34%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -209.33 Million TWD | -51.27% |
| 2022 | -138.38 Million TWD | 43.07% |
| 2021 | -243.09 Million TWD | -273.89% |
| 2020 | -65.01 Million TWD | 55.53% |
| 2019 | -146.19 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -216.27 Million TWD | 1.11% |
| 2024 Q1 | -216.27 Million TWD | -3.31% |
| 2023 Q4 | -209.33 Million TWD | 1.3% |
| 2023 FY | -209.33 Million TWD | -51.27% |
| 2023 Q3 | -212.08 Million TWD | -81.95% |
| 2023 Q2 | -116.56 Million TWD | 2.89% |
| 2023 Q1 | -120.03 Million TWD | 13.26% |
| 2022 Q4 | -138.38 Million TWD | 1.63% |
| 2022 FY | -138.38 Million TWD | 43.07% |
| 2022 Q3 | -140.68 Million TWD | 0.0% |
| 2021 FY | -243.09 Million TWD | -273.89% |
| 2020 FY | -65.01 Million TWD | 55.53% |
| 2019 FY | - TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -171.712% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 20.756% |
| Level Biotechnology Inc. | -453.9 Million TWD | 53.881% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -73.624% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -6.589% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 141.88% |
| GlycoNex Incorporation | -148.56 Million TWD | -40.905% |
| VBI | -25.31 Million TWD | -726.9% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 619.888% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 251.7% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 20.277% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 784.603% |
| Visgeneer Inc. | 31.28 Million TWD | 769.154% |
| Mycenax Biotech Inc. | 207 Million TWD | 201.125% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 69.242% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -55.929% |
| Neith Corporation | -150.31 Million TWD | -39.27% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 133.681% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -263.068% |
| Enimmune corporation | -314.15 Million TWD | 33.366% |
| TaiRx, Inc. | -147.86 Million TWD | -41.57% |
| CHO Pharma, Inc. | -203.79 Million TWD | -2.721% |
| EirGenix Inc. | -4.58 Billion TWD | 95.437% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -146.969% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 273.191% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 93.495% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 34.05% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -956.569% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 758.109% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 512.448% |
| RBC Bioscience Corporation | 422.18 Million TWD | 149.584% |
| BiOptic Inc. | 12.59 Million TWD | 1762.468% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 77.834% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -106.273% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -26.736% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 166.483% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -225.458% |
| NaviFUS Corp. | -123.12 Million TWD | -70.015% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 382.694% |
| Sinew Pharma Inc. | -160.34 Million TWD | -30.555% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 13.458% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 37.951% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 49.268% |
| AP Biosciences Inc | -196.52 Million TWD | -6.518% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 130.395% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -1730.358% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 74.769% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 115.423% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 49.542% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -45.512% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 36.668% |
| TCI GENE Inc. | -689.25 Million TWD | 69.628% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -76.006% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 84.01% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1122.008% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -105.495% |
| PharmaEngine, Inc. | -860.8 Million TWD | 75.681% |
| Savior Lifetec Corporation | -812.54 Million TWD | 74.237% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 30.213% |
| OBI Pharma, Inc. | -398.22 Million TWD | 47.432% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 42.713% |
| Acepodia, Inc. | -6.02 Billion TWD | 96.523% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 93.846% |